文献速递关节外科

风险与回报:医院比外科医生更有动力照护高风险关节置换患者

Risk Versus Reward: Hospitals Incentivized More Than Surgeons to Care for Riskier Arthroplasty Patients.
PubMed 文献 · J Arthroplasty · 2024-05-10

该研究基于2021年Medicare数据,分析初次全关节置换术(TJA)患者风险与外科医生及医院报销的关系。结果显示,病情较重队列(HCC风险评分≥1.5)的外科医生平均报销低于较健康队列($1,021.91 vs $1,060.13,P < .001),而医院对较重队列的平均报销显著高于较健康队列($13,950.66 vs $8,430.46)。作者认为这体现了对复杂患者照护激励的差异,医院承担额外风险获得更高报酬,而外科医生对较重患者手术平均收入更低。

要点

  • 病情较重TJA患者的外科医生平均报销低于较健康患者($1,021.91 vs $1,060.13,P < .001)。
  • 病情较重TJA患者的医院平均报销高于较健康患者($13,950.66 vs $8,430.46)。
  • 两分析中较重队列所有评估合并症发生率均显著更高(P < .001)。

核心结论

  • 该研究表明,病情较重患者初次TJA的外科医生平均报销低于较健康患者,而医院报销则更高。
  • 这体现了对复杂患者照护激励的差异:医院因承担额外风险获得更高报酬,而外科医生对较重患者行TJA平均收入更低。
  • 作者认为此类数据应 informing 未来政策,以确保复杂患者持续获得关节置换照护。

研究设计与样本

  • 使用「2021 Medicare Physician and Other Provider」和「2021 Medicare Inpatient Hospitals」文件。
  • 收集患者合并症特征,包括平均患者分级条件类别(HCC)风险评分。
  • 外科医生数据包括2021年向Medicare计费的所有初次TJA手术(住院和门诊),医院数据包括所有此类住院事件。
  • 所有事件按HCC风险评分≥1.5分为「较重队列」,<1.5分为「较健康队列」。

主要发现

  • 2021年共有386,355例初次全髋和全膝关节置换术向Medicare计费并纳入外科医生分析。
  • 较重队列外科医生平均报销为$1,021.91,低于较健康队列的$1,060.13(P < .001)。
  • 医院分析纳入112,012例Medicare TJA住院患者,较重队列医院平均报销为$13,950.66,高于较健康队列的$8,430.46。
  • 两分析中较重患者队列所有评估合并症发生率均显著更高(P < .001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this study was to assess the relationship between risk and reimbursement for both surgeons and hospitals among Medicare patients undergoing primary total joint arthroplasty (TJA). METHODS: The "2021 Medicare Physician and Other Provider" and "2021 Medicare Inpatient Hospitals" files were used. Patient comorbidity profiles were collected, including the mean patient hierarchal condition category (HCC) risk score. Surgeon data included all primary TJA procedures (inpatient and outpatient) billed to Medicare in 2021, while hospital data included all such inpatient episodes. Surgeon and hospital reimbursements were collected. All episodes were split into a "sicker cohort" with an HCC risk score of 1.5 or more and a "healthier cohort" with HCC risk scores less than 1.5. Variables were compared across cohorts. RESULTS: In 2021, 386,355 primary total hip and knee arthroplasty procedures were billed to Medicare and were included. The mean surgeon reimbursement among the sicker cohort was $1,021.91, which was less than for the healthier cohort of $1,060.13 (P < .001). Meanwhile, for the hospital analysis, 112,012 Medicare TJA patients were admitted as inpatients and included. The mean reimbursement to hospitals was significantly greater for the sicker cohort at $13,950.66, compared to the healthier cohort of $8,430.46. For both analyses, the sicker patient cohorts had a significantly higher rate of all comorbidities assessed (P < .001). CONCLUSIONS: This study demonstrates that mean surgeon reimbursement was lower for primary TJA among sicker patients in comparison to their healthier counterparts, while hospital reimbursement was higher for sicker patients. This represents a discrepancy in the incentivization of care for complex patients, as hospitals receive increased remuneration for taking on extra risk, while surgeons get paid less on average for performing TJA on sicker patients. Such data should inform future policy to assure continued access to arthroplasty care among complex patients.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Haglin JM, Brinkman JC, Austin RP, et al. Risk Versus Reward: Hospitals Incentivized More Than Surgeons to Care for Riskier Arthroplasty Patients. J Arthroplasty. 2024. PMID: 38735550. doi:10.1016/j.arth.2024.05.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。